Read our Privacy Policy.
To learn more about ongoing studies with investigational MDMA-assisted therapy, please visit clinicaltrials.gov.
Midomafetamine (MDMA) capsules have not been approved by any regulatory agency. The safety and efficacy of midomafetamine have not been established for the treatment of PTSD.
We are committed to conducting research and development to determine the safety and efficacy of our investigational products, and their potential to help address unmet needs in mental health. We have completed two Phase 3 trials and are designing an additional Phase 3 trial to evaluate midomafetamine (MDMA) capsules in combination with psychological intervention for treating adults with post-traumatic stress disorder (PTSD).
Read our Privacy Policy.
To learn more about ongoing studies with investigational MDMA-assisted therapy, please visit clinicaltrials.gov.